Views & Analysis Ensuring access: how to help patients seeking experimental t... The impact of the debate on the Right-to-Try laws in the US and what needs to be done to improve access to innovative drugs.
News Bayer hits "turning point" in recovery plan, says CEO Bayer's pharma unit has reached a "turning point" in its growth trajectory as sales of new medicines rose 6.4% in Q3, says CEO Bill Anderson.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.